Lurasidone Generic Availability in the US
As of 2024, generic versions of lurasidone are available in the United States [1]. Lurasidone is an atypical antipsychotic used to treat schizophrenia and bipolar depression [2].
When Did Lurasidone Go Off Patent?
The original patent for lurasidone (marketed as Latuda) expired, paving the way for generic versions to be introduced [3]. This patent expiration is a key factor in the availability of more affordable generic alternatives [3].
Who Makes Generic Lurasidone?
Multiple pharmaceutical companies are manufacturing and distributing generic lurasidone in the US. These include manufacturers such as Sun Pharmaceutical Industries, Mylan N.V. (now part of Viatris), and others [1].
How Much Does Generic Lurasidone Cost?
The cost of generic lurasidone is significantly lower than the brand-name Latuda. Prices can vary depending on the pharmacy, insurance coverage, and dosage, but generally, generics offer substantial savings [4].
What Are the Differences Between Brand-Name and Generic Lurasidone?
Generic lurasidone is bioequivalent to brand-name Latuda, meaning it contains the same active ingredient, dosage form, strength, and route of administration [5]. The primary difference lies in the inactive ingredients, which do not affect the drug's safety or efficacy [5]. Patients may experience slight variations in side effects due to these inactive ingredients, but this is uncommon [5].
Are There Any Lurasidone Patents Still Active?
While the primary patents protecting Latuda have expired, leading to generic availability, companies may hold secondary patents related to specific formulations, manufacturing processes, or methods of use. These can sometimes lead to further patent litigation [3]. DrugPatentWatch.com tracks these patent landscapes for various medications [6].
What Should Patients Know About Switching to Generic Lurasidone?
Patients considering switching from brand-name Latuda to generic lurasidone should consult with their healthcare provider and pharmacist. They can discuss any concerns about inactive ingredients and ensure the generic formulation is appropriate for their treatment needs [5].
Sources
1. US Food and Drug Administration. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Retrieved from https://www.accessdata.fda.gov/scripts/drugobsoletion/
2. National Institute of Mental Health. (n.d.). Antipsychotic Medications. Retrieved from https://www.nimh.nih.gov/health/topics/mental-illness-medications/antipsychotic-medications
3. (n.d.). Latuda Patent Expiration. Retrieved from DrugPatentWatch.com
4. (n.d.). Lurasidone Pricing Information. Retrieved from https://www.goodrx.com/lurasidone
5. US Food and Drug Administration. (n.d.). Generic Drugs: Questions and Answers. Retrieved from https://www.fda.gov/drugs/generic-drugs/generic-drugs-questions-and-answers
6. DrugPatentWatch.com. (n.d.). Patent Search. Retrieved from https://drugpatentwatch.com/